Dr. Reddy's Labs Appoints Erez Israeli as New COO
Dr. Reddy’s Laboratories Ltd. has named Mr. Erez Israeli, former President and CEO of Enzymotec, as the new Chief Operating Officer (COO) and Global Head of Generics & PSAI. The incumbent COO, Mr. Abhijit Mukherjee, retired on March 31. Mr. Israeli will report to Dr. Reddy’s Co-Chairman & CEO, Mr. G. V. Prasad. Mr. Israeli’s former stint has been with companies like Teva where he held several positions of responsibility including Vice President Marketing & Sales for North America, Vice President Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO, Growth Markets.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DIC Opens Sustainable Food Contact Coatings Production Facility in Indonesia
-
Cambodia’s Agricultural Exports Hit $2.42 Billion in 7 Months Cashew Surges 59 Percent While Rice and Pepper Slip
-
Lianhong NewTech H1 Net Profit Jumps 43 Percent Despite Revenue Dip New Materials Portfolio Drives Growth
-
Belarus and China Sign Updated Protocol for Poultry Exports 188 Belarusian Producers Registered for Chinese Market
-
Nepal’s Rice Planting Rate Hits 91 Percent After Heavy Rains Madesh and Koshi Regions Rebound from Drought
-
Vietnam’s Seafood Exports Surge 20 Percent to $6.2 Billion China Hong Kong Overtakes US as Top Market Amid Trade Headwinds
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
-
EU RASFF Issues 8 Alerts on Chinese Food and Products in One Week Heavy Metals and Unauthorized Additives Trigger Recalls
-
ATSP Composite Breakthrough Offers Aerospace Self-Healing and Shape Recovery Published in Top Journals
-
Adnoc L&S Surges 40 Percent in Revenue and Unveils $3 Billion Expansion Plan for 2029
Recommend Reading
-
Huayi Group Lists 25 Percent Stake in Edoco China for 320 Million Yuan Signals Major Asset Optimization Push
-
CN New Energy and BTR Sign Over 10 Billion Yuan Anode Material Deal to Accelerate Battery Innovation
-
JIEYANG KMT Gas Unveils 1.59 Billion Yuan Project to Produce 300000 Tons Food-Grade CO₂ and 400000 Tons Hydrogen Peroxide
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
Raw material prices rise, this week phthalic anhydride prices in China have significantly increased
-
This Week's Aniline Market Remains Firm (10.20-10.24)
-
Insufficient Support, Shandong Cyclohexanone Market in Decline
-
Poor Demand Continues to Drive Down Butadiene Market
-
China's Soda Ash Market Trend Weak (8.11-8.18)